| Oct 14 |
TriSalus Life Sciences to Participate in the 2024 Maxim Healthcare Virtual Summit
|
| Sep 23 |
TriSalus Announces Journal of Vascular and Interventional Radiology Publication of Data that Demonstrate Improved Therapeutic Delivery of Glass Microspheres to Solid Tumors With PEDD™ Method via the TriNav® Infusion System
|
| Sep 14 |
TriSalus Life Sciences Inc (TLSI) CEO Buys Shares
|
| Aug 1 |
TriSalus Life Sciences to Host Second Quarter 2024 Financial Results Conference Call
|
| Jul 1 |
TriSalus Life Sciences Announces Completion of Exchange Offer and Consent Solicitation
|
| Jun 26 |
TriSalus Life Sciences Announces Expiration and Results of Exchange Offer and Consent Solicitation Relating to Warrants
|
| May 15 |
TriSalus Life Sciences, Inc. (TLSI) Q1 2024 Earnings Call Transcript
|
| May 15 |
TriSalus Life Sciences reports Q1 GAAP EPS of -$0.60, revenue of $6.5M
|
| May 15 |
TriSalus Reports Q1 2024 Financial Results and Business Update
|
| May 7 |
TriSalus Life Sciences Appoints Liselotte Hyveled to its Board of Directors
|
